ADAM17 Fluorometric Drug Discovery Kit, Enzo Life Sciences

Supplier: Enzo Life Sciences
BML-AK310-0001
76002-366EA 670 USD
76002-366
ADAM17 Fluorometric Drug Discovery Kit, Enzo Life Sciences
Assays Protein Assays
Designed to screen ADAM17 (TACE) inhibitors using a quenched fluorogenic peptide. The ADAM17 Fluorometric (also known as fluorimetric) Drug Discovery Kit is a complete assay system designed to screen ADAM17 (TACE) inhibitors using a quenched fluorogenic peptide: Mca-PLAQAV-Dpa-RSSSR-NH2. Mca fluorescence is quenched by the Dpa group until cleavage by proteases separates the two moieties. The assays are performed in a convenient 96-well microplate format. The kit is useful to screen inhibitors of ADAM17, a potential therapeutic target. The compound GM6001 is also included as a prototypic control inhibitor.

Ordering information: Contains 1 vial ADAM17 enzyme, 1 vial Substrate (Mca-PLAQAV-Dpa-RSSSR-NH2), 1 vial DMSO, 1 vial CALIBRATION STANDARD, 1 vial control inhibitor (GM6001), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR